Zhitong Finance App News, Angel Yeast (600298.SH) announced that in order to enhance the company's core competitiveness in the field of biological manufacturing, Enzyme Formulation Company, a wholly-owned subsidiary of the company, plans to invest about 370 million yuan to build a new synthetic biology pilot testing base project. The project is expected to start in March 2027, with a construction period of 16 months. The implementation of the project will help build an integrated pilot platform, accelerate the pace of industrialization of products such as novel industrial enzyme preparations, novel microbial proteins, and synthetic biological aqueous phase extraction, and are in line with the development direction of the national biomantry industry.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.